Showing results (111-120 of 168) with videos related to

Sort By:
Pageof 17
Medical Microbiology and Immunology|August 11, 2010
Human immunodeficiency virus type-1 group M quasispecies evolution: diversity and divergence in patients co-infected with active tuberculosisT Biru, T Lennemann, M Stürmer, et al.
European Journal of Medical Research|July 6, 2006
Pharmacokinetics and tolerability of a combination of indinavir, lopinavir and ritonavir in multiply pretreated HIV-1 infected adultsNils von Hentig, A Müller, C Rottmann, et al.
International Journal of STD & AIDS|March 3, 2007
Dose reduction effective in alleviating symptoms of saquinavir toxicityC Stephan, A Carlebach, C Rottmann, et al.
European Journal of Medical Research|December 16, 2010
Mutations in the C-terminal region of the HIV-1 reverse transcriptase and their correlation with drug resistance associated mutations and antiviral treatmentI Michels, S Staszewski, L Gürtler, et al.
The Journal of Pharmacy and Pharmacology|February 19, 2002
In-vitro cytotoxic/cytostatic activity of anionic liposomes containing vinblastine against leukaemic human cell linesH Maswadeh, C Demetzos, K Dimas, et al.
European Journal of Medicinal Chemistry|April 26, 2011
Curcumin analogues as possible anti-proliferative & anti-inflammatory agentsA-M Katsori, M Chatzopoulou, K Dimas, et al.
European Journal of Medical Research|October 26, 2011
Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label studyS Esser, A Haberl, F Mulcahy, et al.
AIDS (London, England)|March 15, 1997
Reductions in HIV-1 disease progression for zidovudine/lamivudine relative to control treatments: a meta-analysis of controlled trialsS Staszewski, A M Hill, J Bartlett, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
Patterns of resistance and cross-resistance to human immunodeficiency virus type 1 reverse transcriptase inhibitors in patients treated with the nonnucleoside reverse transcriptase inhibitor lovirideV Miller, M P de Béthune, A Kober, et al.
AIDS (London, England)|February 1, 1993
The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative GroupD A Cooper, P O Pehrson, C Pedersen, et al.
Pageof 17